Xincat Brand Ranking
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
XINCAT

XINCAT

Shandong Zibo Xinda Pharmaceutical Co., Ltd.
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Shandong Zibo Xinda Pharmaceutical Co., Ltd. was established in 1993. It is a wholly-owned subsidiary of Shandong Xinhua Pharmaceutical Co., Ltd. and a high-tech enterprise integrating scientific research, production and service. Xinda Pharmaceuticals aims to "fresh and healthy, safe," and "update and shared with each other" as its business philosophy. It is committed to providing high-quality medicines and health services to the society.

The company has R&D platforms such as provincial enterprise technology center, Zibo Diabetes Drug Engineering Technology R&D Center, etc., and has signed a cooperation agreement with Shandong University to establish a strategic alliance for technological innovation in major new drug creation industry, thereby continuously improving its own technical level. We now have a total of 32 valid knowledge patents, including 8 invention patents and 19 new drug certificates. It has 1 national first-class new drug and 3 national second-class new drug. The workshops have all passed the new version of GMP certification.

At present, the company's products are oral solid preparations, with categories such as cephalosporins, penicillins, and ordinary; dosage forms are tablets, hard capsules, granules, and dry suspensions. The main product "Xindaro" (Cefacro) series products were introduced in China by the company in 1994. They have successively launched three dosage forms: capsules, granules, and sustained-release tablets. They are a famous domestic antibiotic brand for children and adults. Ranked among the top of similar varieties. "Chusing" is a cefuroxime dispersed tablet, which is the second generation of oral cephalosporin antibiotics. "Dunling" national new drug has a stable and long-lasting effect on lowering sugar, protecting the kidneys, and effectively reduces and improves cardiovascular complications.

Looking to the future, Xinda Pharmaceutical is taking it as its mission to revitalize national medicine. With a high sense of social responsibility, through continuous technological innovation and a scientific, rigorous and responsible attitude, it will continue to provide safe, effective and economical medicines to the society. Dedicated to serve the health of all mankind.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号